Uncovering the true identity of naïve pluripotent stem cells

Trends in Cell Biology

Volumn 23, Issue 9, 2013, Pages 442-448

  Welling, Maaike ^a   Geijsen, Niels ^a,b  

^a HUBRECHT INSTITUTE   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

2i culture conditions; Blastocyst; Diapause; Epiblast; Germ cell signature

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BETA CATENIN; FIBROBLAST GROWTH FACTOR 4; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; OCTAMER TRANSCRIPTION FACTOR 4; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG; LEUKEMIA INHIBITORY FACTOR; TRANSCRIPTION FACTOR;

BLASTOCYST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL RENEWAL; CELL STRUCTURE; DEMETHYLATION; DEVELOPMENT; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION; GERM CELL; HISTONE MODIFICATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PLURIPOTENT STEM CELL; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; REVIEW; WNT SIGNALING PATHWAY; ANIMAL; ANIMAL EMBRYO; CYTOLOGY; GENETICS; INNER CELL MASS; METABOLISM; MOUSE;

MURINAE;

ANIMALS; BLASTOCYST INNER CELL MASS; CELL DIFFERENTIATION; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; HUMANS; LEUKEMIA INHIBITORY FACTOR; MICE; PLURIPOTENT STEM CELLS; TRANSCRIPTION FACTORS;

EID: 84882895492     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2013.04.004     Document Type: Review

References (69)

1. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
2. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:7634-7638.
3. Nichols J., Smith A. Naive and primed pluripotent states. Cell Stem Cell 2009, 4:487-492.
4. Thomson J.A., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
5. Brons I.G., et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007, 448:191-195.
6. Tesar P.J., et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
7. Buecker C., et al. A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. Cell Stem Cell 2010, 6:535-546.
8. Hanna J., et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9222-9227.
9. Wang W., et al. Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:18283-18288.
10. Li W., et al. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 2009, 4:16-19.
11. Hochedlinger K. Embryonic stem cells: testing the germ-cell theory. Curr. Biol. 2011, 21:R850-R852.
12. Zwaka T.P., Thomson J.A. A germ cell origin of embryonic stem cells?. Development 2005, 132:227-233.
13. Brinster R.L. The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med. 1974, 140:1049-1056.
14. Matsui Y., et al. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 1992, 70:841-847.
15. Tada T., et al. Epigenotype switching of imprintable loci in embryonic germ cells. Dev. Genes Evol. 1998, 207:551-561.
16. Guan K., et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 2006, 440:1199-1203.
17. Donovan P.J., de Miguel M.P. Turning germ cells into stem cells. Curr. Opin. Genet. Dev. 2003, 13:463-4671.
18. Ko K., et al. Induction of pluripotency in adult unipotent germline stem cells. Cell Stem Cell 2009, 5:87-96.
19. Batlle-Morera L., et al. Parameters influencing derivation of embryonic stem cells from murine embryos. Genesis 2008, 46:758-767.
20. Nichols J., Smith A. The origin and identity of embryonic stem cells. Development 2011, 138:3-8.
21. Macfarlan T.S., et al. Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature 2012, 487:57-63.
22. Hayashi K., et al. Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 2008, 3:391-401.
23. Buehr M., et al. Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biol. Reprod. 2003, 68:222-229.
24. Tang F., et al. Tracing the derivation of embryonic stem cells from the inner cell mass by single-cell RNA-Seq analysis. Cell Stem Cell 2010, 6:468-478.
25. Chu L.F., et al. Blimp1 expression predicts embryonic stem cell development in vitro. Curr. Biol. 2011, 21:1759-1765.
26. Hajkova P., et al. Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 2008, 452:877-881.
27. Bao S., et al. The germ cell determinant Blimp1 is not required for derivation of pluripotent stem cells. Cell Stem Cell 2012, 11:110-117.
28. Gillich A., et al. Epiblast stem cell-based system reveals reprogramming synergy of germline factors. Cell Stem Cell 2012, 10:425-439.
29. Ohinata Y., et al. Blimp1 is a critical determinant of the germ cell lineage in mice. Nature 2005, 436:207-2013.
30. Yamaji M., et al. Critical function of Prdm14 for the establishment of the germ cell lineage in mice. Nat. Genet. 2008, 40:1016-1022.
31. Yamaji M., et al. PRDM14 Ensures naive pluripotency through dual regulation of signaling and epigenetic pathways in mouse embryonic stem cells. Cell Stem Cell 2013, 12:368-382.
32. Leitch H.G., et al. Naive pluripotency is associated with global DNA hypomethylation. Nat. Struct. Mol. Biol. 2013, 20:311-316.
33. Ptak G.E., et al. Embryonic diapause is conserved across mammals. PLoS ONE 2012, 7:e33027.
34. Lopes F.L., et al. Embryonic diapause and its regulation. Reproduction 2004, 128:669-678.
35. Nichols J., et al. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 2001, 128:2333-2339.
36. Stewart C.L., et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992, 359:76-79.
37. Brook F.A., Gardner R.L. The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:5709-5712.
38. Tarin J.J., Cano A. Do human concepti have the potential to enter into diapause?. Hum. Reprod. 1999, 14:2434-2436.
39. Conover J.C., et al. Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells. Development 1993, 119:559-565.
40. Rose T.M., et al. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro. Cytokine 1994, 6:48-54.
41. Takeda K., et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:3801-3804.
42. Okamoto I., et al. Epigenetic dynamics of imprinted X inactivation during early mouse development. Science 2004, 303:644-649.
43. Chazaud C., et al. Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK pathway. Dev. Cell 2006, 10:615-624.
44. Rossant J., et al. Lineage allocation and asymmetries in the early mouse embryo. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2003, 358:1341-1348.
45. Chambers I., et al. Nanog safeguards pluripotency and mediates germline development. Nature 2007, 450:1230-1234.
46. Singh A.M., et al. A heterogeneous expression pattern for Nanog in embryonic stem cells. Stem Cells 2007, 25:2534-2542.
47. Furusawa T., et al. Gene expression profiling of mouse embryonic stem cell subpopulations. Biol. Reprod. 2006, 75:555-561.
48. Toyooka Y., et al. Identification and characterization of subpopulations in undifferentiated ES cell culture. Development 2008, 135:909-918.
49. Silva J., et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 2008, 6:e253.
50. Snow M.H., Bennett D. Gastrulation in the mouse: assessment of cell populations in the epiblast of tw18/tw18 embryos. J. Embryol. Exp. Morphol. 1978, 47:39-52.
51. Nichols J., et al. Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat. Med. 2009, 15:814-818.
52. Hanna J., et al. Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 2009, 4:513-524.
53. Buehr M., et al. Capture of authentic embryonic stem cells from rat blastocysts. Cell 2008, 135:1287-1298.
54. Li P., et al. Germline competent embryonic stem cells derived from rat blastocysts. Cell 2008, 135:1299-1310.
55. Ying Q.L., et al. The ground state of embryonic stem cell self-renewal. Nature 2008, 453:519-523.
56. ten Berge D., et al. Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells. Nat. Cell Biol. 2011, 13:1070-1075.
57. Marks H., et al. The transcriptional and epigenomic foundations of ground state pluripotency. Cell 2012, 149:590-604.
58. Wray J., et al. The ground state of pluripotency. Biochem. Soc. Trans. 2010, 38:1027-1032.
59. Bernstein B.E., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
60. Silva J., et al. Nanog is the gateway to the pluripotent ground state. Cell 2009, 138:722-737.
61. Miyanari Y., Torres-Padilla M.E. Control of ground-state pluripotency by allelic regulation of Nanog. Nature 2012, 483:470-473.
62. Buganim Y., et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 2012, 150:1209-1222.
63. Polo J.M., et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012, 151:1617-1632.
64. Maekawa M., et al. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 2011, 474:225-229.
65. Dejosez M., et al. Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell 2008, 133:1162-1174.
66. Najm F.J., et al. Isolation of epiblast stem cells from preimplantation mouse embryos. Cell Stem Cell 2011, 8:318-325.
67. O'Leary T., et al. Tracking the progression of the human inner cell mass during embryonic stem cell derivation. Nat. Biotechnol. 2012, 30:278-282.
68. Lengner C.J., et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 2010, 141:872-883.
69. Tomoda K., et al. Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell 2012, 11:91-99.